North America is witnessing continued development in blood preparation and management due to well-established healthcare infrastructure, increasing surgical procedures, and growing demand for safe and reliable blood products. Healthcare providers and blood banks across the region are investing in modern collection, processing, screening, cold-chain, and inventory management technologies to improve operational efficiency and product safety. Rising adoption of automated systems and digital tracking solutions, along with increasing demand for specialized blood components and plasma-derived therapies, is expected to support the expansion of blood preparation activities across North America.
Market Size and Growth Outlook
The Blood Preparation Market size is anticipated to witness growth from US$ 53.63 Billion in 2025 to US$ 83.66 Billion in 2034, at a CAGR of 5.72%. The market covers whole blood, blood components, and blood derivatives used across applications associated with thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, and other conditions. Demand is being supported by increasing surgical procedures, oncology treatments, cardiovascular interventions, renal care, emergency medicine, and the expanding use of plasma-derived therapies. The market is forecast to maintain steady expansion as healthcare systems prioritize reliable blood availability, quality control, standardized processing, and improved inventory management.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00023674
Automation Transforming Blood Preparation Processes
Automation is emerging as an important trend across blood banks and healthcare facilities. Traditional manual procedures are increasingly being complemented or replaced by automated component separation, barcode-based tracking, digital inventory systems, connected storage equipment, and automated quality-control workflows. These technologies can reduce manual variability, improve traceability, support inventory visibility, and minimize product wastage. Digital systems also enable healthcare providers to monitor storage conditions and product movement more efficiently. As blood banks seek greater operational consistency and compliance with quality requirements, investment in automation and integrated technology platforms is expected to remain a significant contributor to Blood Preparation Market Growth throughout the forecast period.
Rising Demand for Blood Components
Blood components represent the largest product segment, accounting for approximately 42–45% of the market in 2025 and projected to grow at a CAGR of 5.6–6.0% during 2026–2034. Red blood cells, plasma, and platelets enable targeted transfusion practices and are extensively used across surgery, oncology, emergency care, cardiovascular treatment, and critical care. The growing preference for component-based transfusion rather than indiscriminate whole-blood use is encouraging blood banks to enhance separation capabilities and inventory planning. Improvements in screening, processing, storage, and distribution are further supporting the availability and quality of individual components.
Expansion of Plasma-Derived Medicines
The growing importance of plasma-derived medicines is another major trend influencing the industry. Plasma-derived products such as immunoglobulins and clotting factors are used in the management of immune deficiencies, bleeding disorders, and specialized hematological conditions. Many countries remain dependent on imported plasma-derived products, creating opportunities for local plasma collection, fractionation partnerships, contract manufacturing, and supply-chain development. This situation is particularly relevant in emerging economies where healthcare infrastructure and pharmaceutical capabilities are expanding. Increased attention toward donor recruitment, plasma collection, quality systems, and domestic manufacturing is expected to create new opportunities across the blood preparation ecosystem.
Thromboembolic and Cardiovascular Conditions Supporting Demand
The increasing burden of thromboembolic and cardiovascular conditions is supporting demand for blood-related products and therapies. Pulmonary embolism, venous thromboembolism, cardiovascular complications, and conditions requiring anticoagulation management create continuing requirements for diagnostic, therapeutic, and hospital-based blood management solutions. The report notes that the US experiences substantial annual venous thromboembolism cases, reinforcing the importance of anticoagulation and related clinical pathways. Hospitals are increasingly emphasizing standardized protocols for risk assessment, treatment, monitoring, and post-discharge care, creating sustained demand for products and technologies supporting blood management and hematology services.
North America Maintains Market Leadership
North America accounted for approximately 38–41% of the market in 2025 and is expected to register a CAGR of 5.0–5.4% during 2026–2034. Established blood transfusion practices, advanced healthcare infrastructure, specialized hematology services, hospital procurement capabilities, and increasing adoption of automated blood-bank systems are supporting regional growth. The US represents approximately 78–82% of the North American market and is expected to expand at a CAGR of 4.9–5.3%. Strong demand from cardiovascular care, orthopedic procedures, cancer treatment, renal disease management, and pulmonary embolism treatment is expected to sustain regional opportunities.
Asia Pacific Offers Strong Growth Potential
Asia Pacific is projected to be one of the fastest-growing regional markets, with a 2025 share of approximately 20–23% and an expected CAGR of 6.8–7.3% from 2026 to 2034. China, Japan, India, South Korea, and Australia are key contributors to regional development. Expansion of hospitals and diagnostic facilities, government-supported donor programs, improvements in blood safety policies, and growing pharmaceutical manufacturing capabilities are strengthening the regional ecosystem. Increasing healthcare expenditure and investments in blood-bank modernization are also encouraging adoption of advanced collection, processing, screening, storage, and traceability technologies.
Digital Traceability and Supply Chain Modernization
Digital traceability is expected to become increasingly important as healthcare organizations seek end-to-end visibility across blood and plasma supply chains. Integrated systems can connect donor records, testing results, processing information, storage conditions, transportation data, and utilization records. Predictive analytics can further support demand forecasting, stock rotation, shortage identification, and expiry reduction. These capabilities can improve operational efficiency while strengthening regulatory reporting, recall management, and hemovigilance. As procurement decisions increasingly consider quality, traceability, and service reliability, suppliers offering connected digital solutions are likely to gain competitive advantages.
Get Full Report: https://www.theinsightpartners.com/buy/TIPRE00023674
Emerging Market Opportunities
Emerging economies present substantial opportunities for blood-bank modernization. Suppliers of collection systems, component-processing technologies, screening platforms, cold-storage equipment, consumables, and digital management solutions can benefit from investments in healthcare infrastructure. Public-private partnerships, training programs, managed services, and modular technologies can help address infrastructure and resource constraints. Countries experiencing hospital expansion, rising surgical volumes, and stronger government-supported blood safety initiatives are particularly attractive. Recurring demand for maintenance, consumables, testing support, and software can also create sustainable revenue opportunities beyond initial equipment deployment.
Competitive Landscape and Top Players
- AstraZeneca PLC
- Sanofi S.A.
- LEO Pharma A/S
- Bristol Myers Squibb Company
- Baxter International Inc.
- Pfizer Inc.
- Portola Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Shandong East Chemical Industry Co., Ltd.
- Celgene Corporation
Future Market Trends
The industry is expected to increasingly move toward localized plasma fractionation, regional supply-chain resilience, advanced cold-chain systems, and integrated digital platforms. Healthcare providers and governments are seeking to reduce dependence on external supplies and strengthen domestic availability of critical blood products and derivatives. At the same time, automation and data-driven inventory management are expected to improve resource allocation and reduce wastage. These trends will encourage manufacturers and service providers to focus not only on product availability but also on regulatory compliance, traceability, workflow integration, and long-term supply continuity.
About US
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets. The Blood Preparation Market report provides market sizing, forecasts, segmentation analysis, regional insights, competitive analysis, market dynamics, growth drivers, and strategic intelligence to support informed business decisions.
Contact Us
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
